Home > Insider Trading > Filing (0001104659-24-008796)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1868279	Arrivent Biopharma Inc.	AVBP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1245624	James Healy	C/O Arrivent Biopharma, Inc. 18 Campus Boulevard, Suite 100 Newtown Square PA 19073		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-01-30	1,252,308	$0.00	1,252,308	No	4	C	Indirect	Sofinnova Venture Partners XI, L.P.
Common Stock	Acquisiton	2024-01-30	444,444	$18.00	1,696,752	No	4	P	Indirect	Sofinnova Venture Partners XI, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	Sofinnova Venture Partners XI, L.P.
No	4	P	Indirect	Sofinnova Venture Partners XI, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2024-01-30	1,252,308	$0.00	1,252,308	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-15.21 basis.
The shares are directly held by Sofinnova Venture Partners XI, L.P. ("SVP XI"). Sofinnova Management XI, L.P. ("SM XI LP") is the general partner of SVP XI and Sofinnova Management XI, L.L.C. ("SM XI") is the general partner of SM XI LP. The Reporting Person is a managing member of SM XI and may be deemed to share voting and dispositive power over the shares held by SVP XI. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
Reflects shares purchased in the Issuer's initial public offering.
The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering.
Not applicable.